Annual report pursuant to Section 13 and 15(d)

Income Taxes (Details)

v2.4.0.8
Income Taxes (Details) (USD $)
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Income Tax Disclosure [Abstract]      
Deferred tax assets before valuation allowance $ 49,205,121 $ 33,721,726  
Net operating loss carryforwards 118,528,911 80,900,000  
Operating loss carryforwards due to stock-based compensation tax deductions in excess of book compensation expense 15,200,000 14,100,000  
R&D credit carryforwards 7,388,463 6,546,049  
Net operating loss carryforwards expired   20,800,000  
Net tax credit carryforwards expired   1,100,000  
Loss from Cardiosonix 13,000 14,000 19,000
Net operating loss carryforwards in Israel $ 7,600,000 $ 7,600,000